FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageus.nlm.vsac
Resource TypeValueSet
IdValueSet-2.16.840.1.113883.3.464.1003.110.12.1084.json
FHIR VersionR4
Sourcehttps://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.110.12.1084/expansion
URLhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084
Version20190315
Statusactive
Date2022-03-03T18:46:01-05:00
NameHibVaccine3DoseScheduleAdministered
TitleHib Vaccine (3 dose schedule) Administered
Realmus
Authorityhl7
Purpose(Clinical Focus: The purpose of this value set is to represent concepts for a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
sctSNOMED codes used in this IG
cptCurrent Procedural Terminology (CPT®)
ValueSet
2.16.840.1.113883.3.464.1003.110.11.1153HiB Vaccine (3 dose schedule) Administered
2.16.840.1.113883.3.464.1003.110.11.1156HiB Vaccine (3 dose schedule) Administered

Narrative

No narrative content found in resource


Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.110.12.1084",
  "meta": {
    "versionId": "10",
    "lastUpdated": "2023-12-21T17:43:03.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-03-10"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2019-03-15"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1084",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.110.12.1084"
    }
  ],
  "version": "20190315",
  "name": "HibVaccine3DoseScheduleAdministered",
  "title": "Hib Vaccine (3 dose schedule) Administered",
  "status": "active",
  "experimental": false,
  "date": "2022-03-03T18:46:01-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent concepts for a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent a 3-dose haemophilus influenzae type b (Hib) vaccination.),(Exclusion Criteria: No exclusions.)",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1153"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1156"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:2a5a6394-e639-4e97-b5ff-8f6bc1ba88ff",
    "timestamp": "2025-05-23T22:18:38-04:00",
    "total": 8,
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "127787002",
        "display": "Administration of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170343007",
        "display": "Administration of first dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170344001",
        "display": "Administration of second dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170345000",
        "display": "Administration of third dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20250301",
        "code": "170346004",
        "display": "Administration of booster dose of vaccine product containing only Haemophilus influenzae type b antigen (procedure)"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "90647",
        "display": "Haemophilus influenzae type b vaccine (Hib), PRP-OMP conjugate, 3 dose schedule, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "90697",
        "display": "Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "90748",
        "display": "Hepatitis B and Haemophilus influenzae type b vaccine (Hib-HepB), for intramuscular use"
      }
    ]
  }
}